Congratulations
@sanjum
and our Endovascular Center Team for earning a prestigious AHA grant entitled "A Comprehensive Assessment of Arterial and Venous Thrombotic Complications in Patients with COVID-19"
@ajaykirtane
@crfheart
More guidance on Cath Lab related issues during
#COVID19
pandemic from our SCAI ELM group. More to come from this group of interventional cardiologists and
@SCAI
@SrihariNaiduMD
@mszerlip
Hope to see you there next Sunday! LBTs, live cases and three outstanding sessions on femoropopliteal disease, CLI, and really interesting case conference.
@roblookstein
@EricSecemskyMD
@ehrin_armstrong
What is
@sahilparikhmd
looking forward to at TCT Connect? “A five-hour dedicated program for endovascular specialists from all over the world!” Join us for the TCT
#endovascular
program on Sunday, October 18.
#TCTConnect
#TCT2020
UPDATE: Treatment of Peripheral Arterial Disease with Paclitaxel-Coated Balloons and Paclitaxel-Eluting Stents Potentially Associated with Increased Mortality - Letter to Health Care Providers . Science must lead the way.
Live case of complex LM bifurcation from Columbia University Irving Medical Center - lucky that I get to learn from my brother Manish and buddies Dimitrios Karmpaliotis and
@ajaykirtane
every day.
#TCT2019
#everycaseisalivecase
UPDATE: Risk of Mortality Associated with Paclitaxel-Coated Devices to Treat Peripheral Arterial Disease is No Longer Supported Based on Data and Analyses - Letter to Health Care Providers
Breaking at
#VEITH2019
: Announcing the LIFE-BTK pivotal IDE clinical trial to evaluate the safety & effectiveness of ESPRIT BTK, a new everolimus eluting bioresorbable scaffold intended for treating critical limb ischemia!
Read about the
#innovativetech
:
My gratitude to our incredible fellows who have worked tirelessly during the height of the surge of
#COVID19
to stem the tide. We are here to support your training now and in the future. We are in your debt.
@DrTGupta
@MatthewTFinn
@IngrassiaMD
@ajaykirtane
Of all the many things I love about TCT, by far my favorite activity is catching up with my former fellows. I marvel at their amazing accomplishments.
#TCT2019
#TCT2019
Registration Is Now Open! Join us in San Francisco for world-class education and hands-on training. Register by May 30th for the lowest rates:
A must for all final year interventional fellows. Congenital Heart Disease, Advanced Endovascular and Structural fellows also welcome to join their specific tracks!
@jgranadacrf
"It’s critically important for physicians and other healthcare professionals to be educated and trained on the latest endovascular treatments." -
@sahilparikhmd
, Director of the TCT Endovascular Program
Every day Dr. Craig Smith, Chair of the Dept of Surgery, sends out a
#Covid_19
update. We will be posting them here each evening.
This is the COVID-19 update for today, 3/20/20
Thanks to the many dedicated HCW out there taking care of all of these patients with
#COVID19
related disease as well as the "normal" emergencies that cannot be overlooked right now.
@SCAI
@mszerlip
@SrihariNaiduMD
@caldera_99
@MIT
@harvardmed
@MGHVascular
Thank you papa. A full circle moment indeed. My thanks to all of our co-investigators and patients who shared in the journey with us to bring forward this new therapy. I hope this opens a new era of innovation and treatments for patients with PAD.
Awesome way to spend my weekend not traveling to lecture! Great job to all of the amazing volunteers who helped to get this fundraiser rolling for
#stillmanreadathon
@stillmanreads
@ Tenafly Public Library
What a day at TCT Endovascular in alliance with
@VEITHsymposium
. Great cases, lectures, debates and panel discussions. Thanks to the attendees, faculty and supporters. Hope to see you at tomorrow’s SFA breakfast and FDA town hall meeting re: PTX featuring
@DrKKatsanos
.
The
#TCT2019
endovascular program begins with a full day of sessions this morning in room 156-158. Learn the latest in endovascular science, novel devices, and best clinical practices in vascular disease management.
@VEITHsymposium
“This is an evolving situation where even the best-laid plans can rapidly change,” said
@sahilparikhmd
. Also,
@MVMadhavanMD
added: "Staying healthy, staying safe, and, as much as possible, being protected is of equal importance to treating that individual patient.”
Hear ye, hear ye: We've relaunched our Off Script blog as a year-round affair on
@TCTMD
(adroitly piloted by
@kwanleemd
at meetings past). Here's our first, penned by
@sahilparikhmd
reminiscing about the
#FDA
's paclitaxel device
#AdComm
meeting in June.
#cardiotwitter
Come to the VEITH Symposium for Hands on training in Radial and Tibial Vascular Access and SFA technologies for complex interventions with world class faculty.
@VEITHsymposium
@djc795
A great day for patients with vascular disease and their doctors. It's always good to have options, especially options that have been subjected to rigorous scientific scrutiny.
@rwyeh
Thank you my friend. We have come a long way from the Bigelow Medical Service! Congrats to you on Agent! Local vascular drug delivery for the win.
@skathire
Congratulations Sek! How appropriate to have these data presented today! Happy Diwali! All of us South Asians touched by a family history of atherosclerosis salute you!
@ajaykirtane
@TheLancet
Congratulations
@ajaykirtane
and team on this landmark study. Many moons ago, I was privileged to work with some great friends in Cleveland to enroll the first patient in this Trio cohort. Incredible to see these results in press.
@rwyeh
@JDMossMD
There’s something nice about the old days! At least you actually had to go to the bedside to round! And, I think HB and I (and countless others) taught you some other things that you might still remember and use every day.